Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457294) titled '1% Clascoterone Cream for the Treatment Acne Vulgaris' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Condition:
Acne Vulgaris
Intervention:
Drug: 1% Clascoterone Cream
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: May 4, 2026
Target Sample Size: 692
To know more, visit https://clinicaltrials.gov/study/NCT07457294
Published by HT...